research
Outcome and biomarker analysis from a multi-centre phase 2 study of ipilimumab in combination with carboplatin and etoposide (ICE) as first line therapy for extensive stage small cell lung cancer.
- Publication date
- 1 January 2016
- Publisher
- 'Elsevier BV'